These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1486 related items for PubMed ID: 18565348

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 4. Histomolecular classification of adult diffuse gliomas: the diagnostic value of immunohistochemical markers.
    Figarella-Branger D, Maues de Paula A, Colin C, Bouvier C.
    Rev Neurol (Paris); 2011 Oct 01; 167(10):683-90. PubMed ID: 21889777
    [Abstract] [Full Text] [Related]

  • 5. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.
    Marko NF, Prayson RA, Barnett GH, Weil RJ.
    Genomics; 2010 Jan 01; 95(1):16-24. PubMed ID: 19835948
    [Abstract] [Full Text] [Related]

  • 6. [Towards a molecular classification of gliomas].
    Hoang-Xuan K, Idbaih A, Mokhtari K, Sanson M.
    Bull Cancer; 2005 Apr 01; 92(4):310-6. PubMed ID: 15888387
    [Abstract] [Full Text] [Related]

  • 7. Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas.
    Watanabe T, Nakamura M, Kros JM, Burkhard C, Yonekawa Y, Kleihues P, Ohgaki H.
    Acta Neuropathol; 2002 Mar 01; 103(3):267-75. PubMed ID: 11907807
    [Abstract] [Full Text] [Related]

  • 8. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.
    von Deimling A, Louis DN, von Ammon K, Petersen I, Wiestler OD, Seizinger BR.
    Cancer Res; 1992 Aug 01; 52(15):4277-9. PubMed ID: 1353411
    [Abstract] [Full Text] [Related]

  • 9. [Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour].
    Born PW, Broholm H, Laursen H.
    Ugeskr Laeger; 2006 Oct 30; 168(44):3813-6. PubMed ID: 17118240
    [Abstract] [Full Text] [Related]

  • 10. [Correlation between loss of heterozygosity on chromosome 1p and 19q and expression of MGMT, p53 and Ki-67 proteins in gliomas].
    Huang L, Jiang T, Yuan F, Li GL, Xu LX, Cui Y.
    Zhonghua Zhong Liu Za Zhi; 2011 Oct 30; 33(10):752-8. PubMed ID: 22335907
    [Abstract] [Full Text] [Related]

  • 11. Histopathology, classification, and grading of gliomas.
    Kleihues P, Soylemezoglu F, Schäuble B, Scheithauer BW, Burger PC.
    Glia; 1995 Nov 30; 15(3):211-21. PubMed ID: 8586458
    [Abstract] [Full Text] [Related]

  • 12. [Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice].
    Fontaine D, Vandenbos F, Lebrun C, Paquis V, Frenay M.
    Rev Neurol (Paris); 2008 Nov 30; 164(6-7):595-604. PubMed ID: 18565359
    [Abstract] [Full Text] [Related]

  • 13. Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas.
    Okamoto Y, Di Patre PL, Burkhard C, Horstmann S, Jourde B, Fahey M, Schüler D, Probst-Hensch NM, Yasargil MG, Yonekawa Y, Lütolf UM, Kleihues P, Ohgaki H.
    Acta Neuropathol; 2004 Jul 30; 108(1):49-56. PubMed ID: 15118874
    [Abstract] [Full Text] [Related]

  • 14. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors.
    Shukla B, Agarwal S, Suri V, Pathak P, Sharma MC, Gupta D, Sharma BS, Suri A, Halder A, Sarkar C.
    Neurol India; 2009 Jul 30; 57(5):559-66. PubMed ID: 19934553
    [Abstract] [Full Text] [Related]

  • 15. [Update on the molecular biology of gliomas: towards a pathomolecular classification of gliomas].
    Idoate MA, Echeveste J.
    Rev Neurol; 2009 Jul 30; 44(4):217-24. PubMed ID: 17311212
    [Abstract] [Full Text] [Related]

  • 16. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype.
    Smith JS, Alderete B, Minn Y, Borell TJ, Perry A, Mohapatra G, Hosek SM, Kimmel D, O'Fallon J, Yates A, Feuerstein BG, Burger PC, Scheithauer BW, Jenkins RB.
    Oncogene; 1999 Jul 15; 18(28):4144-52. PubMed ID: 10435596
    [Abstract] [Full Text] [Related]

  • 17. Low-grade gliomas -- current concepts.
    Schramm J, Blümcke I, Ostertag CB, Schlegel U, Simon M, Lutterbach J.
    Zentralbl Neurochir; 2006 May 15; 67(2):55-66. PubMed ID: 16673237
    [Abstract] [Full Text] [Related]

  • 18. Neuropathological and molecular aspects of low-grade and high-grade gliomas.
    Michotte A, Neyns B, Chaskis C, Sadones J, In 't Veld P.
    Acta Neurol Belg; 2004 Dec 15; 104(4):148-53. PubMed ID: 15742604
    [Abstract] [Full Text] [Related]

  • 19. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
    Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, Ladd C, Pohl U, Hartmann C, McLaughlin ME, Batchelor TT, Black PM, von Deimling A, Pomeroy SL, Golub TR, Louis DN.
    Cancer Res; 2003 Apr 01; 63(7):1602-7. PubMed ID: 12670911
    [Abstract] [Full Text] [Related]

  • 20. Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas.
    Kitange G, Misra A, Law M, Passe S, Kollmeyer TM, Maurer M, Ballman K, Feuerstein BG, Jenkins RB.
    Genes Chromosomes Cancer; 2005 Jan 01; 42(1):68-77. PubMed ID: 15472895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 75.